LCMV, an enveloped RNA arenavirus, is rare among laboratory animals, but is readily transmissible to lab workers. Infected mice generally do not present clinical signs. LCMV infection may be diagnosed by ELISA, measuring rapidly rising antibody titers (8-12 days after infection) to LCMV antigen. Mice infected with LCMV are not suitable for animal research due to suppression of cellular immunity, increased sensitivity to viruses and endotoxins, and inhibition of tumor induction or transplantation. Besides infecting animals, LCMV may also contaminate cell lines, transplantable tumors and other biological products; these should be tested by mouse antibody production (MAP), using ELISA to detect anti-LCMV after immunization.

RecombiVirus ELISAs are 2nd generation immunoassays using purified recombinant, antigenic proteins of animal viruses. The Creative Diagnostics G.Pig LCMV IgG ELISA is designed with high sensitivity for the detection of antibodies derived from vaccination or natural LCMV infection.